Elite Pharmaceuticals, Inc.

ELTP · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$26,617$21,738$11,315$8,293
Short-Term Investments$0$0$0$0
Receivables$40,872$36,219$29,207$18,454
Inventory$18,165$19,357$16,240$20,158
Other Curr. Assets$139$548$976$1,145
Total Curr. Assets$85,794$77,861$57,739$48,050
Property Plant & Equip (Net)$13,401$13,809$14,099$13,865
Goodwill$0$0$0$0
Intangibles$5,638$5,638$5,638$7,241
Long-Term Investments$0$458$454$449
Tax Assets$11,804$13,481$18,366$20,689
Other NC Assets$611$92$92$462
Total NC Assets$31,454$33,478$38,648$42,707
Other Assets$0$0$0$0
Total Assets$117,248$111,339$96,387$90,756
Liabilities
Payables$3,425$5,089$2,958$5,840
Short-Term Debt$961$1,090$5,082$5,121
Tax Payable$0$753$341$506
Deferred Revenue$0$2$6$9
Other Curr. Liab.$6,288$3,828$3,455$3,213
Total Curr. Liab.$10,674$10,763$11,840$14,689
LT Debt$2,355$5,585$5,833$6,057
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$31,960$47,309$25,199$33,565
Total NC Liab.$34,316$52,894$31,032$39,622
Other Liabilities$0$0$0$0
Cap. Leases$0$3,430$3,635$3,835
Total Liabilities$44,989$63,657$42,872$54,311
Equity
Pref Stock$0$0$0$0
Common Stock$1,073$1,068$1,068$1,068
Retained Earnings-$112,886-$126,589-$120,704-$137,702
AOCI$0$0$0$0
Other Equity$173,398$173,203$173,150$173,079
Total Equity$61,585$47,683$53,515$36,446
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$106,574$111,339$96,387$90,756
Net Debt-$23,301-$15,063-$400$2,884